Myomo (MYO) Free Cash Flow (2016 - 2025)
Myomo (MYO) posted Free Cash Flow of -$2.9 million for Q3 2025, up 71.53% on a QoQ basis from -$10.1 million in Q2 2025, and down 58.78% year-over-year from -$7.0 million in Q3 2024.
Myomo (MYO) Free Cash Flow (2016 - 2025) Analysis & Trends
Myomo's Free Cash Flow history runs 10 years deep, the most recent figure standing at -$2.9 million for Q3 2025.
- Quarterly Free Cash Flow fell 58.78% year-over-year to -$2.9 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$16.4 million (down 251.65% YoY) and the FY2024 annual result came in at -$4.7 million, up 26.41% from the prior year.
- Free Cash Flow was -$2.9 million for Q3 2025 at Myomo, up from -$10.1 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $2.5 million in Q4 2024 and bottomed at -$10.1 million in Q2 2025.
- A 5-year average of -$2.5 million and a median of -$2.4 million in 2022 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 204.95% in 2024, while the deepest fall reached 577.31% in 2024.
- Myomo's Free Cash Flow stood at -$1.9 million in 2021, then sank by 31.84% to -$2.5 million in 2022, then gained by 3.25% to -$2.4 million in 2023, then jumped by 204.95% to $2.5 million in 2024, then sank by 215.01% to -$2.9 million in 2025.
- Business Quant data shows MYO's Free Cash Flow at -$2.9 million in Q3 2025, -$10.1 million in Q2 2025, and -$3.3 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2.88 Mn |
| Sep 30, 2025 | -2.88 Mn |
| Jun 30, 2025 | -10.12 Mn |
| Jun 30, 2025 | -10.12 Mn |
| Mar 31, 2025 | -3.35 Mn |
| Mar 31, 2025 | -3.35 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Dec 31, 2024 | 2.51 Mn |
| Sep 30, 2024 | -1.81 Mn |
| Sep 30, 2024 | -1.81 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -2.04 Mn |
| Mar 31, 2024 | -3.31 Mn |
| Mar 31, 2024 | -3.31 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Sep 30, 2023 | -1.77 Mn |
| Jun 30, 2023 | -300,496.00 |
| Jun 30, 2023 | -300,496.00 |